Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper

Thomas Lener, Mario Gimona, Ludwig Aigner, Verena Börger, Edit I. Buzás, Giovanni Camussi, Nathalie Chaput, Devasis Chatterjee, Felipe A. Court, Hernando Antonio Del Portillo, Lorraine O’Driscoll, Stefano Fais · 2015

Read Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper by Thomas Lener, Mario Gimona, Ludwig Aigner, Verena Börger, Edit I. Buzás, Giovanni Camussi, Nathalie Chaput, Devasis Chatterjee, Felipe A. Court, Hernando Antonio Del Portillo, Lorraine O’Driscoll, Stefano Fais (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w2207291742.txt.

Description

Thomas Lener, Mario Gimona, Ludwig Aigner, and many colleagues wrote this position paper in the Journal of Extracellular Vesicles in 2015. It sets out the stance of the International Society for Extracellular Vesicles on applying therapies based on extracellular vesicles, tiny membrane sacs shed by cells, in clinical trials. The hosted sample for this entry preserves only front matter and author affiliations, with no readable abstract or body text, so no recommendations are summarized here.

Catalog record

CREATORThomas Lener, Mario Gimona, Ludwig Aigner, Verena Börger, Edit I. Buzás, Giovanni Camussi, Nathalie Chaput, Devasis Chatterjee, Felipe A. Court, Hernando Antonio Del Portillo, Lorraine O’Driscoll, Stefano Fais
YEAR2015
COLLECTIONPAPERS
FORMATTXT
FILE SIZE182 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEOpenAlex / Journal of Extracellular Vesicles

Source: https://doi.org/10.3402/jev.v4.30087

Browse the full library · About the Tower of Babel